Virus-Like Particles and Nanoparticles for Vaccine Development Against HCMV

Viruses - Switzerland
doi 10.3390/v12010035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Virus Like Particles as a Platform for Cancer Vaccine Development

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2017English

Vaccine Potential of Nipah Virus-Like Particles

PLoS ONE
Multidisciplinary
2011English

Viruses and Virus-Like Particles: Nature's Nanoparticles for Targeted Delivery

European Journal of Nanomedicine
MedicineBioengineeringTheoretical ChemistryBiomedical EngineeringPhysical
2008English

Virus-Like Particles Expressing the Nucleocapsid Gene as an Efficient Vaccine Against Rift Valley Fever Virus

Vector-Borne and Zoonotic Diseases
VirologyInfectious DiseasesMicrobiology
2010English

Development of Recombinant Vaccine Against A(H1N1) 2009 Influenza Based on Virus-Like Nanoparticles Carrying the Extracellular Domain of M2 Protein

Acta Naturae
BiochemistryBiotechnologyMolecular MedicineMolecular Biology
2010English

Vesicular Stomatitis Virus as a Vector to Deliver Virus-Like Particles of Human Norovirus: A New Vaccine Candidate Against an Important Noncultivable Virus

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2011English

Vaccine Nanoparticles for Protection Against HIV Infection

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2017English

Vaccine Efficacy Against Malaria by the Combination of Porcine Parvovirus-Like Particles and Vaccinia Virus Vectors Expressing CS of Plasmodium

PLoS ONE
Multidisciplinary
2012English

Tetravalent Recombinant Dengue Virus-Like Particles as Potential Vaccine Candidates: Immunological Properties

BMC Microbiology
Microbiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy